A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04159701. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Crossover Study to Evaluate the Efficacy and Safety of LY3454738 in Adults With Chronic Spontaneous Urticaria Inadequately Controlled With H1-Antihistamines
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The reason for this study is to see if the study drug LY3454738 is safe and effective as treatment for participants with hives that are caused by chronic spontaneous urticaria (CSU) and that are not controlled with H1-antihistamines.
Study identification
- NCT ID
- NCT04159701
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 52 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 15, 2019 (Actual)
- Primary completion
- Feb 24, 2021 (Actual)
- Completion
- Feb 24, 2021 (Actual)
- Last update posted
- Mar 11, 2022
2019 – 2021
United States locations
- U.S. sites
- 18
- U.S. states
- 9
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kern Research, Inc | Bakersfield | California | 93301 | — |
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| Antelope Valley Clinical Trials | Lancaster | California | 93534 | — |
| California Allergy and Asthma Medical Group + Research Center | Los Angeles | California | 90025 | — |
| Allergy & Asthma Consultants | Redwood City | California | 94063 | — |
| Florida Center for Allergy & Asthma Research Landman | Aventura | Florida | 33180 | — |
| Florida Center for Allergy & Asthma Research Rodicio | Miami | Florida | 33173 | — |
| Miami Dermatology and Laser Research | Miami | Florida | 33173 | — |
| Sarasota Clinical Research | Sarasota | Florida | 34239 | — |
| ForCare Clinical Research | Tampa | Florida | 33613-1244 | — |
| University of South Florida Asthma, Allergy and Immunology | Tampa | Florida | 33613 | — |
| Treasure Valley Medical Research | Boise | Idaho | 83706 | — |
| Allergy & Asthma Specialists, P.S.C. | Owensboro | Kentucky | 42301 | — |
| Johns Hopkins Asthma and Allergy Center | Baltimore | Maryland | 21224 | — |
| Signature Allergy & Immunology | St Louis | Missouri | 63141 | — |
| Optimed Research, LTD | Columbus | Ohio | 43235 | — |
| Vital Prospects Clinical Research Institute, P.C. | Tulsa | Oklahoma | 74136 | — |
| Northwest Research Center | Portland | Oregon | 97202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04159701, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 11, 2022 · Synced Nov 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.